Correlation between inhibitory effect of quinolones and mycolic acid metabolism in mycobacteria.
Mycolic acids are important components having a significant role in maintaining the rigidity of mycobacterial cell wall. They could also be the barrier for penetration of certain drugs into the bacterial cell. A novel in vitro model system was established for assessing the effect of Ciproflaxacin on mycolic acid metabolism in pathogenic mycobacteria M. Kansasii (which has similar mycolic acid pattern to that from M. leprae) and the effect of norfloxacin in M. intracellulare. These test mycobacteria were exposed in their midlogarithmic phase of growth to 0.5, 1, 2, 3, 4, 5 and 6 micrograms ml of ciprofloxacin and norfloxacin respectively for 1, 2 and 24 hours. Ciprofloxacin completely inhibited the synthesis of mycolates in M. kansasii at 3, 4 and 5 micrograms/ml; whereas norfloxacin exhibited its maximum inhibitory action on mycolic acids in M. intracellulare at 6 micrograms/ml for all the durations of exposure. Inhibition of mycolates directly correlated with bacterial viability which was estimated by colony forming units. The effect of quinolones on mycolic acid metabolism appears to be direct and not secondary to DNA gyrase. The results obtained from this study and our previous findings show that mycolic acid metabolism is affected by various groups of drugs, whose primary sites of activity may be different. The findings of the present study may have significant therapeutic implications in leprosy and other mycobacterial diseases.
Patil
M A
MA
Department of Microbiology, Central JALMA Institute for Leprosy (ICMR), Tajganj, Agra.
Katoch
V M
VM
Venkatesan
K
K
Sharma
V D
VD
Shivannavar
C T
CT
Kanaujia
G V
GV
Agrawal
B M
BM
D002939:Ciprofloxacin / Q000494:pharmacology*; D009161:Mycobacterium / Q000187:drug effects* / Q000378:metabolism; D015269:Mycobacterium avium Complex / Q000187:drug effects; D009171:Mycolic Acids / Q000378:metabolism*; D009170:Nontuberculous Mycobacteria / Q000187:drug effects; D009643:Norfloxacin / Q000494:pharmacology*
D009171:Mycolic Acids; D002939:Ciprofloxacin; D009643:Norfloxacin